drugset / Trial / NCT00087386
Tanespimycin in Treating Patients With Stage III-IV Melanoma
NaSingle-groupOpen-labelTreatment
Summary
This phase II trial is studying how well tanespimycin works in treating patients with stage III or stage IV melanoma. Antitumor antibiotics such as tanespimycin may stop the growth of melanoma by stopping blood flow to the tumor.
Timeline
- Start
- 2004-06
- Primary completion
- 2007-02
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | tanespimycin | Unknown | — | Intravenous |